February 19, 2025
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immune disorders and neurodegenerative conditions Combined with an innovative, high throughput sensor module, SBX uses expanded synthetic molecules to determine the DNA sequence of a target molecule, creating [...]
DKSH Receives Global ISO Certifications for its Supply Chains in Key Markets
February 18, 2025
DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future. Zurich, [...]
Park Systems Expands FX Large Sample AFM Lineup to Power Next-Gen Industrial Innovation
February 18, 2025
Park Systems, a global leader in atomic force microscopy (AFM), has unveiled an expanded FX Large Sample AFM series at SEMICON Korea 2025. Building on the success of Park FX200, which debuted at SEMICON West 2024 and has since gained strong market traction in Germany, Japan, and Korea, Park Systems introduces Park FX300 for 300 [...]
New CEOs for Life Science and Healthcare business sectors and New Chief People Officer
February 18, 2025
The Board of Partners of E. Merck KG, Darmstadt, Germany, has appointed three new members to our Executive Board. Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Science, succeeding Matthias Heinzel, who has decided not to renew his contract Danny Bar-Zohar to [...]
Ready-to-use hiPSC-derived cells help optimize lab workflows.
February 18, 2025
AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes, and neurons. Supplied fully differentiated and available in high-purity formats, these ready-to-use cells help accelerate research by streamlining lab workflows, eliminating the need for in-house differentiation and minimizing preparation time. Provided as functionally validated cells, researchers do not need to spend [...]
February 18, 2025
Collaboration aims to accelerate automation of rapid NGS testing NATICK, Mass. -- Pillar Biosciences, Inc., the leader in Decision Medicine™, has entered into a strategic NGS automation application development agreement and co-marketing partnership with Hamilton Company. As part of this agreement, Hamilton will develop automation scripts and supporting technical and commercial literature for selected, commercially available, research-use-only (RUO) NGS panels [...]
Sapio Sciences Expands Leadership Team to Drive Growth
February 18, 2025
Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new [...]
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
February 18, 2025
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral genome engineering system, supporting the development and manufacture of immune cell- and stem cell-based therapies. The TcBuster System has been widely used by researchers to introduce large [...]
Nuclera appoints William J. Kullback as Non-Executive Director
February 18, 2025
Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc. Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the appointment of William J. Kullback to its Board of Directors as a Non-Executive Director (NED). Bill is [...]
February 18, 2025
SAN DIEGO, CALIFORNIA -- Rancho BioSciences, the premier tech-enabled data science partner for biopharma, welcomes Bristol Myers Squibb (BMS) back for the 2nd phase of The Single-Cell Data Science Consortium. This continuing initiative aims to build on Phase 1’s foundation, bringing together leading pharmaceutical companies with shared goals and needs in the realm of single-cell data. [...]

